Discover 1,971 paid clinical trials in Boca Raton, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,971
A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer
for
HPV-Related Squamous Cell Carcinoma
Location: Miami FL, Middletown NJ, Basking Ridge NJ, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT06563479
Phase3, Recruiting
RELIVE (Randomized Evaluation of Less Invasive Ventricular Enhancement) Trial
for
Left Ventricle Remodeling, Left Ventricle Dilated, CHF
Location: Miami FL, Hershey PA, Chicago IL, Kansas City MO,
Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain
for
Osteoarthritis Knee Pain
Location: Coral Gables FL, Orlando FL, Winter Park FL,
Sponsor: Saol Therapeutics Inc
Sex: All
Age: 40+
Code: NCT07226258
Phase3, Recruiting
Treatment for Youth (Ages 8 to 16 Years Old) With Misophonia (U-HEAR)
for
Misophonia
Location: Coral Gables FL, Saint Petersburg FL
Sponsor: University of South Florida
Sex: All
Age: 8 - 16
Code: NCT04365543
Recruiting
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
for
Breast Cancer, TNBC - Triple-Negative Breast Cancer,
Location: Miami FL, Tampa FL, Nashville TN, Baltimore MD,
Sponsor: Processa Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06568692
Phase2, Recruiting
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
for
Type 1 Diabetes
Location: Miami FL, Gainesville FL, Atlanta GA, Asheville NC,
Sponsor: SAb Biotherapeutics, Inc.
Sex: All
Age: 5 - 40
Code: NCT07187531
Phase2, Recruiting
Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
for
Extensive Stage Lung Small Cell Cancer
Location: Miami FL, Charlottesville VA, Baltimore MD, Columbus OH,
Sponsor: PrECOG, LLC.
Sex: All
Age: 18+
Code: NCT07057791
Phase2, Recruiting
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)